The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
399 - We have an HCP-gated educational website/app containing endorsed medical education. We would like to post a program comprised of KOL-presented patient cases containing a video segment featuring one of that KOL's patients. What is the patient allowed to speak about on the video (e.g. their quality of life post-therapy...)?
-
First you have to decide if the case study presentation is advertising or not. If it includes mention of the sponsor's drug, it is usually advertising. Then all statements should be consistent with the Product Monograph and within the standards of the PAAB Code of Advertising Acceptance. You should also consult the Health Canada policy guideline "The Distinction Between Advertising and Other Activities".
